Drug Database
Back to search

United States· US:0173-0889_d400b994-abe7-40a6-a7bd-0fbf45f855ad

Krintafel

A tafenoquine product containing tafenoquine succinate, registered in United States by GlaxoSmithKline LLC.

ATC P01BA07

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedKrintafelATCP01BA07REGISTER NO.US:0173-0889_d400b994…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tafenoquine succinateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TAFENOQUINE SUCCINATE
Manufacturer
GlaxoSmithKline LLC
Country
United States (US)
ATC code
P01BA07
ATC class
Tafenoquine
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    0173-0889-39

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

31 interactions on record for tafenoquine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tafenoquine against other medicinesHow interaction checks work

Tafenoquine · interactions on record

31 records

  • 2 severe
  • 29 moderate

Most severe, free to view

  • DofetilideC01BD04severe
  • PrilocaineN01BB04severe
  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under P01BA07

Tafenoquine, as other registers publish it.

All tafenoquine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/06fffb52-7810-4f70-93ef-e8cf01d61a6f
GET /v1/drugs/06fffb52-7810-4f70-93ef-e8cf01d61a6f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "150",
  "substance": "TAFENOQUINE SUCCINATE",
  "productndc": "0173-0889",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA210795",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about tafenoquine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console